Terms: = Uterine cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Treatment
117 results:
1. Long-Term Risk of Reintervention After Surgical Leiomyoma treatment in an Integrated Health Care System.
Mitro SD; Xu F; Lee C; Zaritsky E; Waetjen LE; Wise LA; Hedderson MM
Obstet Gynecol; 2024 May; 143(5):619-626. PubMed ID: 38547478
[TBL] [Abstract] [Full Text] [Related]
2. Gynaecological cancer incidence and mortality trends in a Brazilian State with medium human development index: A 22-year analysis.
da Silva BEB; de Lemos LMD; Moura AR; Ferrari YAC; Lima MS; Santos MO; Lima CA
Cancer Epidemiol; 2024 Feb; 88():102493. PubMed ID: 38056244
[TBL] [Abstract] [Full Text] [Related]
3. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
4. Clinical implications of a cesarean scar pregnancy sonographic evaluation and reporting system.
Meyer R; Friedrich L; Plaschkes R; Toussia-Cohen S; Levin G; Weissbach T; Kassif E; Mashiach R
Eur J Obstet Gynecol Reprod Biol; 2023 Dec; 291():247-251. PubMed ID: 37944212
[TBL] [Abstract] [Full Text] [Related]
5. Deep molecular tracking over the 12-yr development of endometrial cancer from hyperplasia in a single patient.
Reid K; Camacho-Vanegas O; Pandya D; Camacho SC; Qiao RF; Kalir T; Padron-Rhenals MM; Beddoe AM; Dottino P; Martignetti JA
Cold Spring Harb Mol Case Stud; 2023 Dec; 9(4):. PubMed ID: 37848227
[TBL] [Abstract] [Full Text] [Related]
6. WIF1 promoter hypermethylation induce endometrial carcinogenesis through the Wnt/β-catenin signaling pathway.
Zhang B; Ji J; Hu M; Zhou X; Nie Q; Xu H; Jiang C; Fu Y; Li L
Am J Reprod Immunol; 2023 Aug; 90(2):e13743. PubMed ID: 37491917
[TBL] [Abstract] [Full Text] [Related]
7. [treatment and prognosis analysis of 488 patients with FIGO 2018 stage Ⅲc squamous cervical cancer].
Feng T; Shou HF; Yuan SH; Tang HR; Lyu XJ; Yin ZM; Lou HM; Ni J
Zhonghua Fu Chan Ke Za Zhi; 2023 May; 58(5):359-367. PubMed ID: 37217343
[No Abstract] [Full Text] [Related]
8. Fertility-sparing hormonal treatment in patients with stage I endometrial cancer of grade 2 without myometrial invasion and grade 1-2 with superficial myometrial invasion: Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-2001).
Lee AJ; Yang EJ; Kim NK; Kim Y; Suh DH; Kim J; Son JH; Kong TW; Chang SJ; Hwang DW; Park SJ; Kim HS; Yoo JG; Lee SJ; Lee YY; Shim SH
Gynecol Oncol; 2023 Jul; 174():106-113. PubMed ID: 37172410
[TBL] [Abstract] [Full Text] [Related]
9. Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients.
Das S; Babu A; Medha T; Ramanathan G; Mukherjee AG; Wanjari UR; Murali R; Kannampuzha S; Gopalakrishnan AV; Renu K; Sinha D; George Priya Doss C
Med Oncol; 2023 Apr; 40(5):149. PubMed ID: 37060468
[TBL] [Abstract] [Full Text] [Related]
10. PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia.
Xue Y; Dong Y; Lou Y; Lv Q; Shan W; Wang C; Chen X
J Gynecol Oncol; 2023 Jul; 34(4):e53. PubMed ID: 36929579
[TBL] [Abstract] [Full Text] [Related]
11. Incidence and treatment outcomes of uterine cervical cancer in Korea 1999-2018 from the national cancer registry.
Suh DH; Ha HI; Lee YJ; Lim J; Won YJ; Lim MC
J Gynecol Oncol; 2023 Mar; 34(2):e39. PubMed ID: 36731896
[TBL] [Abstract] [Full Text] [Related]
12. Endometrial cancer of the very elderly: Management and survival in the Francogyn population.
Martin FA; Dion L; Nyangoh Timoh K; Dupré PF; Azaïs H; Bendifallah S; Touboul C; Dabi Y; Graesslin O; Raimond E; Costaz H; Kerbage Y; Huchon C; Mimoun C; Koskas M; Akladios C; Lecointre L; Canlorbe G; Chauvet P; Ouldamer L; Levêque J; Lavoué V
Eur J Surg Oncol; 2023 May; 49(5):1023-1030. PubMed ID: 36707344
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of the disease burden trend of malignant tumors of the female reproductive system in China from 2006 to 2020.
Han X; Wang Z; Huang D; Deng K; Wang Q; Li C; Zhu J
BMC Womens Health; 2022 Dec; 22(1):504. PubMed ID: 36476597
[TBL] [Abstract] [Full Text] [Related]
14. Incidence and survival rates of primary uterine carcinosarcoma in Korea: a National cancer Registry study.
Kim SI; Kim JH; Lee C; Ha J; Jung KW; Lim MC
J Gynecol Oncol; 2023 Jan; 34(1):e9. PubMed ID: 36366811
[TBL] [Abstract] [Full Text] [Related]
15. Spirulina phycocyanin extract and its active components suppress epithelial-mesenchymal transition process in endometrial cancer via targeting TGF-beta1/SMAD4 signaling pathway.
Chen HY; Chiang YF; Huang CY; Shieh TM; Kao C; Chang FK; Huang TC; Ali M; Chang HY; Hong YH; Hsia SM
Biomed Pharmacother; 2022 Aug; 152():113219. PubMed ID: 35691155
[TBL] [Abstract] [Full Text] [Related]
16. Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian cancer.
Xu J; Fang Y; Chen K; Li S; Tang S; Ren Y; Cen Y; Fei W; Zhang B; Shen Y; Lu W
Clin Cancer Res; 2022 Aug; 28(16):3590-3602. PubMed ID: 35675036
[TBL] [Abstract] [Full Text] [Related]
17. Increased survival in non-endometrioid endometrial cancer after introducing lymphadenectomy and tailoring radiotherapy - A population-based cohort study.
Åkesson Å; Adok C; Dahm-Kähler P
Eur J Cancer; 2022 Jul; 169():54-63. PubMed ID: 35500461
[TBL] [Abstract] [Full Text] [Related]
18. Utility of germline multi-gene panel testing in patients with endometrial cancer.
Karpel HC; Chern JY; Smith J M; Smith A J; Pothuri B
Gynecol Oncol; 2022 Jun; 165(3):546-551. PubMed ID: 35483985
[TBL] [Abstract] [Full Text] [Related]
19. The therapeutic potential of RNA Polymerase I transcription inhibitor, CX-5461, in uterine leiomyosarcoma.
Kang CW; Hannan KM; Blackburn AC; Loh AHP; Hong KC; Yuan GJ; Hein N; Drygin D; Hannan RD; Coupland LA
Invest New Drugs; 2022 Jun; 40(3):529-536. PubMed ID: 35201535
[TBL] [Abstract] [Full Text] [Related]
20. Distinct Genomic Landscapes in Early-Onset and Late-Onset Endometrial cancer.
Choi J; Holowatyj AN; Du M; Chen Z; Wen W; Schultz N; Lipworth L; Guo X
JCO Precis Oncol; 2022 Feb; 6():e2100401. PubMed ID: 35108035
[TBL] [Abstract] [Full Text] [Related]
[Next]
